Trastuzumab Biosimilars Market 2023 Research By Size, Industry Trends, Share, Top Players And Forecast 2032 | Amgen Inc., Pfizer Inc., Merck & Co., Biocon Limited, Mylan Inc.

trastuzumab biosimilars market

The Business Research Company’s Trastuzumab Biosimilars Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Trastuzumab Biosimilars Global Market Report 2023 evaluates trastuzumab biosimilars market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):

The global trastuzumab biosimilars market grew from $2.64 billion in 2022 to $3.36 billion in 2023 at a compound annual growth rate (CAGR) of 27.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The trastuzumab biosimilars market is expected to grow from $8.86 billion in 2027 at a CAGR of 27.4%.

The Trastuzumab Biosimilars Market Segments In The Report Are:

Trastuzumab Biosimilars Market By Product:
Other Products

Trastuzumab Biosimilars Market By Indication:
Adjuvant Breast Cancer
Metastatic Breast Cancer
Metastatic Gastric Cancer
Other Indications

Trastuzumab Biosimilars Market By Distribution Channel:
Hospital Pharmacy
Online Pharmacy

Top Key Players
Amgen Inc.
Pfizer Inc.
Merck & Co.
Biocon Limited
Mylan Inc.

North America was the largest region in the trastuzumab biosimilar market in 2022.

Get More Information On The Trastuzumab Biosimilars Market Report:

The table of contents in TBRC’s trastuzumab biosimilars market report includes:
1. Executive Summary
2. Trastuzumab Biosimilars Market Characteristics
3. Trastuzumab Biosimilars Market Trends And Strategies
4. Trastuzumab Biosimilars Market – Macro Economic Scenario
5. Trastuzumab Biosimilars Market Size And Growth
27. Trastuzumab Biosimilars Market Competitive Landscape And Company Profiles
28. Trastuzumab Biosimilars Pipeline Analysis
29. Key Mergers And Acquisitions In The Trastuzumab Biosimilars Market
30. Trastuzumab Biosimilars Market Future Outlook and Potential Analysis
31. Appendix

List Of Tables 

Table 1: Global Historic Market Growth, 2017-2022, $ Billion 

Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion 

Table 3: Global Trastuzumab Biosimilars Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 

Table 4: Global Trastuzumab Biosimilars Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 

Table 5: Global Trastuzumab Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 

Table 46: Amgen Inc. Financial Performance 

Table 47: Pfizer Inc Financial Performance 

Table 48: Samsung Bioepis Financial Performance 

Table 49: Merck & Co. Financial Performance 

Table 50: Biocon Limited Financial Performance

Read Related Reports

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us: 
The Business Research Company 
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
Healthcare Blog: 
Global Market Model: